Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...

A repurposed epilepsy drug called sultiame cut breathing interruptions during sleep by up to 50% in adults with moderate-to-severe obstructive sleep apnea, according to results from a major European ...

This Nature Outlook is editorially independent, produced with financial support from Avadel. Miranda cannot remember a time in her life when she did not have insomnia. The 23 year old, who asked for ...

A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Subscribe to read this story ad-free Get unlimited access to ad-free ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Weight loss pills and injections are often touted as miracle drugs. Research shows that they can help you lose weight, better help you manage type II diabetes, and even reduce your risk of heart ...

Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. The Massachusetts biotech reported May 19 that AD109 met the primary endpoint of a phase 3 trial, reducing ...

An international study shows new drug improves sleep, health in patients diagnosed with obesity and sleep apnea. Researchers at University of California San Diego School of Medicine and international ...

Testing for a new sleep apnea drug has proven exceptionally successful. Not only has the drug allowed some patients to abandon their CPAP machines entirely, but it has also helped boost weight loss ...